<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="app1table4" position="float"><object-id pub-id-type="doi">10.7554/eLife.31486.037</object-id><label>Appendix 1&#8212;table 4.</label><caption><title>Effect of sp<sup>2</sup> sidechain mutations on phase separation.</title><p>Phase separation critical concentration values for the N-terminus (1-236) of human Ddx4 and three mutants, 9FtoA and 14FtoA, as reported in (<xref ref-type="bibr" rid="bib56">Nott et al., 2015</xref>), and RtoK, where all arginine residues have been mutated to lysine&#160;(<xref ref-type="bibr" rid="bib5">Brady et al., 2017</xref>), as well as for the C-terminus (445-632) of human FMR1 and one mutant with all arginine residues mutated to lysine.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Sample</th><th valign="top">Concentration at which phase separation is observed <break/>(conditions)</th><th valign="top"># F</th><th valign="top"># R</th><th valign="top">Total #</th><th valign="top">Mw (Da)</th></tr></thead><tbody><tr><td><bold>Ddx4 1&#8211;236</bold></td><td><bold>(24&#176;C, 20 mM Na<sub>2</sub>PO<sub>4</sub> pH 6.5, 100 mM NaCl)</bold></td><td/><td/><td/><td/></tr><tr><td>WT</td><td>~2 mg/mL</td><td>14</td><td>24</td><td>236</td><td>25430</td></tr><tr><td>9FtoA</td><td>~100 mg/mL</td><td>5</td><td>24</td><td>236</td><td>24745</td></tr><tr><td>14FtoA</td><td>~350 mg/mL</td><td>0</td><td>24</td><td>236</td><td>24364</td></tr><tr><td>RtoK</td><td>Not observed up to 400 mg/mL</td><td>14</td><td>0</td><td>236</td><td>24758</td></tr><tr><td><bold>FMR1 445&#8211;632</bold></td><td><bold>(4&#176;C, 20 mM Na<sub>2</sub>PO<sub>4</sub> pH 7.4, 2 mM DTT)</bold></td><td/><td/><td/><td/></tr><tr><td>WT</td><td>~16 mg/mL</td><td>2</td><td>28</td><td>188</td><td>20573</td></tr><tr><td>RtoK</td><td>Not observed up to 216 mg/mL</td><td>2</td><td>0</td><td>188</td><td>19789</td></tr></tbody></table></table-wrap>